rheumatoid arthritis

March 6, 2015March 6, 2015

Tocilizumab Monotherapy More Cost-Effective Than Adalimumab in Rheumatoid Arthritis

A recent study found that from a US payer’s perspective tocilizumab (TCZ) mono therapy is more cost-effective when compared with adalimumab (ADA) monotherapy in patients with severe rheumatoid arthritis for ... Read more

March 5, 2015March 5, 2015

“Million Man Study” Finds Blocking Inflammation Long-Term Can Cause Collateral Damage

News, rheumatoid arthritis

Inflammation, one of the human body’s responses to trauma or other damaging stimuli, is a symptom largely regarded as something we would rather do without. Although inflammation one of the ... Read more

March 3, 2015March 3, 2015

Ultrasonographic Scans of the Hand Provide Rheumatoid Arthritis Disease Information

News, rheumatoid arthritis

According to a recent study, ultrasonographic scanning of a patients’ hands provides valuable disease activity information in those suffering with rheumatoid arthritis or systemic sclerosis. The study recently published in The Egyptian ... Read more

February 27, 2015February 27, 2015

What Allows Remission in Patients with Early Rheumatoid Arthritis?

News, rheumatoid arthritis

A team led by researchers at the Leiden University Medical Center in The Netherlands recently revealed the possibility of remission in patients with undifferentiated arthritis or early rheumatoid arthritis (RA). ... Read more

February 26, 2015February 26, 2015

Hypertension Increases the Risk for Cardiac Disease in Rheumatoid Arthritis

News, rheumatoid arthritis

In a recent study entitled “The Impact of Traditional Cardiovascular Risk Factors on Cardiovascular Outcomes in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis,” researchers suggest that traditional cardiovascular ... Read more

February 25, 2015February 25, 2015

Galapagos Reports Last Patient in DARWIN 1 RA Clinical Trials Has Completed 12 Weeks Of Treatment

News, rheumatoid arthritis

Galapagos NV is a clinical stage biotechnology company specialized in small molecule therapies that is developing medicines with novel mechanisms of action. The company has recently announced that the last patient in their DARWIN 1 trial treated with filgotinib has completed 12 weeks ... Read more

February 24, 2015February 24, 2015

Scientists Discover “Marvel Molecule” Potential Treatment for Array of Inflammatory Diseases

News, rheumatoid arthritis

An international team of researchers based out of Trinity College Dublin in Ireland and the University of Queensland in Australia have discovered what is being dubbed a “marvel molecule” that ... Read more

February 23, 2015February 23, 2015

International Study to Focus on Inflammation’s Role in Arthritis, Heart Failure

News, rheumatoid arthritis

In order to understand the role of inflammation in both rheumatoid arthritis and heart failure, an international team of medical researchers is beginning a novel investigation based at the Canadian Dalhousie Medical ... Read more

February 18, 2015February 18, 2015

New Biomarker Can Identify Patients Resistant to Methotrexate for Rheumatoid Arthritis

News, rheumatoid arthritis

A recent study published in the journal PNAS suggests a potential new biomarker for the identification of rheumatoid arthritis (RA) patients who are unlikely to respond to methotrexate therapy. The study is entitled ... Read more

February 17, 2015February 17, 2015

Gastrointestinal, Urogenital Infections May Lower Risk of Rheumatoid Arthritis

News, rheumatoid arthritis

According to a recent study from the Institute of Environmental Medicine in Stockholm, gastrointestinal and urogenital infections lower the risk of rheumatoid arthritis (RA). In the study titled ”Recent infections ... Read more